Facebook
Linkedin
Twitter
Home
R&D
FINANCE
MANUFACTURING
APPROVALS
SUPPLY CHAIN
LAUNCHES
EVENTS
EVENTS NEWS
EVENT LISTINGS
APPOINTMENTS
Search
Facebook
Linkedin
Twitter
Home
R&D
FINANCE
MANUFACTURING
APPROVALS
SUPPLY CHAIN
LAUNCHES
EVENTS
EVENTS NEWS
EVENT LISTINGS
APPOINTMENTS
Search
Home
2021
Yearly Archives: 2021
Real-world evidence demonstrates significant difference in fracture risk reduction for osteoporosis...
28th August 2021
Lilly and Lycia to develop novel lysosomal targeting chimera degraders
27th August 2021
Shape and Roche enter AAV-based RNA editing tech collaboration
27th August 2021
AbbVie secures European approval for Rinvoq
26th August 2021
Genevant and Takeda to develop novel nonviral gene therapies for rare...
26th August 2021
Pfizer acquires Trillium in $2.26bn deal
26th August 2021
1
...
11
12
13
Page 13 of 13
News
AbbVie and Xilio Therapeutics to develop novel tumor-activated immunotherapies
14th February 2025
AbbVie and Xilio Therapeutics, a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, have announced a collaboration and...
Duchenne muscular dystrophy market to reach $5.2 billion in 7MM by 2033, forecasts GlobalData
14th February 2025
The Duchenne muscular dystrophy (DMD) market across the seven major markets (7MM*) is set to grow from $2.3 billion in 2023 to $5.2 billion...
Royalty Pharma to provide $250m R&D funding in Biogen lupus collaboration
13th February 2025
Royalty Pharma has entered into an agreement with Biogen to provide research and development (R&D) funding of up to $250 million for litifilimab, a...